Allogeneic Stem Cell Transplantation

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Lazarus, Hillard M. (Επιμελητής έκδοσης), Laughlin, Mary J. (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Totowa, NJ : Humana Press, 2010.
• Σειρά: Contemporary Hematology
• Θέματα: Medicine.; Hematology.; Medicine & Public Health.

 Since the original publication of Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Allogeneic hematopoietic stem cell transplantation (HSC) has undergone several fast-paced changes. In this second edition, the editors have focused on topics relevant to evolving knowledge in the field in order to better guide clinicians in decision-making and management of their patients, as well as help lead laboratory investigators in new directions emanating from clinical observations. Some of the most respected clinicians and scientists in this discipline have responded to the recent advances in the field by providing state-of-the-art discussions addressing these topics in the second edition. The text covers the scope of human genomic variation, the methods of HLA typing and interpretation of high-resolution HLA results. Comprehensive and up-to-date, Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Second Edition offers concise advice on today's best clinical practice and will be of significant benefit to all clinicians and researchers in allogeneic HSC transplantation. 

 Allogeneic Stem Cell Transplantation: The Last Century -- Full Intensity and Reduced Intensity Allogeneic Transplantation in AML -- Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Progenitor Cell Transplantation for Treatment of Chronic Lymphocytic Leukemia -- The Role of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients in the Era of Tyrosine Kinase Inhibitors -- Allogeneic Transplantation for Hodgkin’s Lymphoma -- Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma -- Non-Hodgkin’s Lymphoma: Allogeneic Reduced Intensity Conditioning -- The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults -- Single Versus Tandem Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma -- Treatment Strategies for Follicular Center Cell Non-Hodgkin’s Lymphoma -- The Role of Transplantation in Favorable-Risk Acute Myeloid Leukemia -- Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults -- Allogeneic Transplantation for Myelodysplastic Syndromes -- Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia -- Allogeneic Transplantation for the Treatment of Multiple Myeloma -- Blood Vs. Marrow Allogeneic Stem Cell Transplantation -- Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors -- Unrelated Donor Transplants -- Update on Umbilical Cord Blood Transplantation -- Selection of Cord Blood Unit(s) for Transplantation -- Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation -- Natural Killer-Cell Based Treatment in Hematopoetic Stem Cell Transplantation -- Cryopreservation of Allogeneic Stem Cell Products -- Concepts and Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation -- Allogeneic Haematopoietic Stem Cell Transplantation and Natural Killer Cell Alloreactivity -- Therapeutic Potential of Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation -- Hematopoietic Stem Cell Transplantation for Thalassemia -- Viral Infections in Hematopoietic Stem Cell Transplant Recipients -- Fungal Infections -- Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation -- Acute Graft Versus Host Disease: Prophylaxis -- Chronic Graft-Versus-Host Disease -- Post-transplant Lymphoproliferative Disorder -- Psychological Care of Adult Allogeneic Transplant Patients -- Second Allogeneic Transplantation: Outcomes and Indications -- Minimal Residual Disease -- Functional Assessment Tools and Co-morbidity Scoring in Hematopoietic Progenitor Cell Transplantation -- Unique Thrombotic and Hemostatic Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantation -- How Much Isolation Is Enough for Allografts? -- Monoclonal Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies -- Treatment of Acute Graft-vs-Host Disease -- The Importance of Non-Human Primate Models for Pre-clinical Studies in Hematopoiesis -- In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation -- Dendritic Cells -- Augmentation of Hematopoietic Stem Cell Transplantation with Anti-cancer Vaccines -- Erratum To.